Neuronetics insider buys 200K shares in open market

Neuronetics, Inc. insider Jorey Chernett purchased 200,000 shares of Common Stock in open-market transactions.

Rhea-AI Filing Summary

Neuronetics, Inc. insider Jorey Chernett purchased 200,000 shares of Common Stock in open-market transactions. He bought 100,000 shares on April 20 and another 100,000 shares on April 21 at weighted average prices around $1.51–$1.58 per share, executed in multiple trades within stated price ranges. After these purchases, he directly holds 9,978,988 shares of Neuronetics common stock.

Insights

Equity markets analyst

Large shareholder increases direct stake with 200,000-share open-market buy.

Jorey Chernett, identified as a ten percent owner of Neuronetics, Inc., executed two open-market purchases totaling 200,000 shares of Common Stock. Transactions on April 20 and April 21 were priced around $1.51–$1.58 per share.

Following these trades, Chernett directly owns 9,978,988 shares. The filing notes that each reported price is a weighted average, with individual trades executed across ranges between $1.50 and $1.59. This points to active accumulation rather than option exercises or tax-driven mechanics.

The transactions are open-market purchases, typically viewed as discretionary decisions. There is no indication of derivative activity or a Rule 10b5-1 trading plan in the provided data, so future filings may further clarify whether this represents a broader accumulation pattern.

Insider Trade Summary

Net Buyer: 200,000 shares

Net Buy 2 txns

Insider Chernett Jorey

Role 10% Owner

Bought 200,000 shs ($309K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	100,000	$1.51	$151K
Purchase	Common Stock	100,000	$1.58	$158K

Holdings After Transaction: Common Stock — 9,978,988 shares (Direct)

Footnotes (2)

1. F1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.59, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.
2. F2. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

Key Figures

Total shares purchased: 200,000 shares Shares purchased April 20: 100,000 shares Price per share April 20: $1.58 per share +4 more

7 metrics

Total shares purchased 200,000 shares Open-market common stock purchases reported on Form 4

Shares purchased April 20 100,000 shares Non-derivative open-market purchase of Common Stock

Price per share April 20 $1.58 per share Weighted average purchase price for April 20 transaction

Shares purchased April 21 100,000 shares Non-derivative open-market purchase of Common Stock

Price per share April 21 $1.51 per share Weighted average purchase price for April 21 transaction

Post-transaction holdings 9,978,988 shares Total Neuronetics common shares directly owned after purchases

Price ranges disclosed $1.50–$1.59 per share Ranges for multiple trades underlying weighted average prices

Key Terms

open-market purchase, weighted average price, ten percent owner, non-derivative, +1 more

5 terms

open-market purchase financial

"transaction_action is described as an open-market purchase of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price, rounded to the nearest cent"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

ten percent owner financial

"reporting person is flagged as a ten percent owner of the issuer"

non-derivative financial

"transaction_type is listed as non-derivative for the Common Stock trades"

beneficial ownership financial

"footnote references providing full information to any security holder regarding purchased shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did STIM major holder Jorey Chernett report?

Jorey Chernett reported buying 200,000 shares of Neuronetics, Inc. common stock in open-market transactions. He purchased 100,000 shares on April 20 and another 100,000 shares on April 21, according to the Form 4 insider trading report.

At what prices did the STIM insider buy Neuronetics shares?

The reported prices are weighted averages of about $1.58 and $1.51 per share. Footnotes state the individual trades occurred in ranges between $1.50 and $1.59 per share, with detailed trade breakdowns available upon request from the insider.

How many Neuronetics (STIM) shares does Jorey Chernett own after these trades?

After the reported purchases, Jorey Chernett directly owns 9,978,988 shares of Neuronetics common stock. This post-transaction holding figure comes directly from the Form 4 and reflects his updated direct ownership position.

Were the Neuronetics (STIM) insider purchases open-market transactions?

Yes. The Form 4 classifies both trades as open-market purchases of Neuronetics common stock. The transaction code is “P,” described as a purchase in open market or private transaction, indicating discretionary buying rather than option exercises or compensation grants.

Did the STIM Form 4 disclose any derivative or option exercises?

No derivative or option exercises are shown in the provided Form 4 data. The derivativeSummary is empty, and both transactions involve non-derivative common stock purchases, emphasizing direct accumulation rather than conversion of existing derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/22/2026 - 09:39 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chernett Jorey

(Last) (First) (Middle)

6222 INDIANWOOD TR.

(Street)

BLOOMFIELD HILLS MICHIGAN 48301

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Neuronetics, Inc. [ STIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/20/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/20/2026		P		100,000	A	$1.58(1)	9,878,988	D
Common Stock	04/21/2026		P		100,000	A	$1.51(2)	9,978,988	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.59, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

2. The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.52, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

	/s/ Jorey Chernett	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)